Home › Therapeutic areas › Ophthalmology › Diabetic Retinopathy
Diabetic Retinopathy (3 companies)
Companies with an active program in Diabetic Retinopathy.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| KOD | Kodiak Sciences | Ophthalmology | 1 | Phase 3 | $6.24B | 8 |
| OCGN | Ocugen | Infectious DiseaseOphthalmology Rare | 1 | Phase 3 | $314M | 12 |
| IRD | Opus Genetics | Ophthalmology Rare | 1 | Approved | $348M | 12 |
No companies match.